AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Oramed Pharmaceuticals Inc.

Foreign Filer Report Nov 28, 2019

6965_rns_2019-11-27_751c081a-54b7-4053-9208-73d146055a7b.htm

Foreign Filer Report

Open in Viewer

Opens in native device viewer

_________ false

����� ����������� ���� 2 379
ORAMED PHARMACEUTICALS INC
Corporation no: 980376008 12537
- - -
Israel Securities Authority Tel Aviv Stock Exchange C001 ( Public ) Reported via MAGNA: 27/11/2019
www.isa.gov.il www.tase.co.il Reference: 2019-02-116284 Time of broadcast: 23:42 23:41:03

Report of Periodic or Interim ReportRegulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onFORM 10-K

ORAMEDPHARMINC_20191127_isa.pdf

Link to filing on foreign stock exchange (optional): _________

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM Date of revision of form structure: 29/10/2019
Address: Avenue of the Americas 01185 , New York 10036   New York , USA Tel: 844-9672633 , 02-5660001 Fax: 02-5660004
E-mail address: [email protected]   Company site: www.oramed.com
Previous names of reporting entity:
Name of the Signatory: GABAY AVRAHAM Position of Signatory in the reporting corporation: CFO & Secretary Name of Employer Company:
Address: Hi-Tech Park, Givat Ram 2/4 , Jerusalem 91390 Telephone: 052-5779725 Facsimile: 02-5660004 E-mail: [email protected] 2
USA

Talk to a Data Expert

Have a question? We'll get back to you promptly.